Alaska ACEP

Use hospitalstatus.alaska.gov to access the Alaska hospital availability and status dashboard, which includes services available at each facility and the contact information to initiate a transfer. You can also access this by clicking the button below.

Hospital Transfer Dashboard

Thank you to those who joined us for a successful part 1 of the MOUD Waiver Training!*

To obtain details on CME claim and instructions on part 2 of the MOUD Waiver Training, please contact Cailey Nickerson: cailey@wsma.org

*Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

At the conclusion of this activity participants should be able to:

1. Screen and identify patients with OUD and define evidence-based treatments.
2. Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
3. Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
4. Explain the process of buprenorphine induction as well as stabilization and maintenance.
5. Discuss all FDA approved antagonist and agonist medications to treat OUD.
6. Discuss basic office protocols including medical record documentation and confidentially.
7. Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
8. Recognize the importance of obtaining a waiver to begin treating patients with OUD.